These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors. Kellerer AM, Rühm W, Walsh L. Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103 [Abstract] [Full Text] [Related]
10. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors. Cordova KA, Cullings HM. Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313 [Abstract] [Full Text] [Related]
16. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA. Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272 [Abstract] [Full Text] [Related]
18. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk. Bennett J, Little MP, Richardson S. Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453 [Abstract] [Full Text] [Related]
19. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons. Sasaki MS, Endo S, Ejima Y, Saito I, Okamura K, Oka Y, Hoshi M. Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767 [Abstract] [Full Text] [Related]
20. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review. Sasaki MS, Endo S, Hoshi M, Nomura T. J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201 [Abstract] [Full Text] [Related] Page: [Next] [New Search]